Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder-Reference-Cited by-同舟云学术

Adjuvant intravesical therapy based on an in vitro cytotoxicity assay in the management of superficial transitional cell cancer of the urinary bladder

Published:2006-11 Issue:5 Volume:98 Page:1012-1017
ISSN:1464-4096
Container-title:BJU International
language:en
Short-container-title:BJU Int

Author:

Saxena Sunita,Agrawal Usha,Agarwal Abhilasha,Murthy Nandagudi Srinivasa,Mohanty Nayan Kumar

Publisher

Wiley

Subject

Urology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-410X.2006.06482.x/fullpdf

Reference30 articles.

1. Cancer statistics, 1999

2. 3 NJ Vogelzang, PT Scardino, WU Shipley, and DS Coffey , Comprehensive Textbook of Genitourinary Oncology. Philadelphia: Lippincott, Williams and Wilkins, 2000 ; 394 -417

3. Antiproliferative Activities of Interferons Against Human Bladder Carcinoma Cell Lines in Vitro

4. Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder a southwest oncology group study

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intravesical Bacillus Calmette-Guérin versus mitomycin C for Ta and T1 bladder cancer;Cochrane Database of Systematic Reviews;2020-01-08

2. Synthesis and Characterization of Carboxylic Acid Conjugated, Hydrophobically Derivatized, Hyperbranched Polyglycerols as Nanoparticulate Drug Carriers for Cisplatin;Biomacromolecules;2010-12-03

3. Serum Th1 and Th2 cytokine balance in patients of superficial transitional cell carcinoma of bladder pre- and post-intravesical combination immunotherapy;Immunopharmacology and Immunotoxicology;2010-01-27

4. Permeation Enhancer-Containing Water-In-Oil Nanoemulsions as Carriers for Intravesical Cisplatin Delivery;Pharmaceutical Research;2009-08-04